# Iron-Chelating Therapy and Friedreich Ataxia

> **NCT00224640** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 15 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Iron chelating intervention

## Key facts

- **NCT ID:** NCT00224640
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2009-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224640, "Iron-Chelating Therapy and Friedreich Ataxia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00224640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*